Meta‐analysis of B type natriuretic peptide and N‐terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction

@article{Ewald2008MetaanalysisOB,
  title={Meta‐analysis of B type natriuretic peptide and N‐terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction},
  author={B. Ewald and D. Ewald and A. Thakkinstian and J. Attia},
  journal={Internal Medicine Journal},
  year={2008},
  volume={38}
}
  • B. Ewald, D. Ewald, +1 author J. Attia
  • Published 2008
  • Medicine
  • Internal Medicine Journal
  • Background:  We set out to review the validity of tests for B type natriuretic peptide (BNP) and N‐terminal pro BNP (NTproBNP) in the diagnosis of clinical heart failure (HF) in primary care and hospital settings and to examine the effect of age. We also examined the accuracy of the test in population screening for left ventricular systolic dysfunction. 
    114 Citations
    N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    • 10
    • PDF
    The role of b-type natriuretic peptide in heart failure management.
    • 14
    • PDF
    Natriuretic peptide testing in primary care patients
    • 2
    Natriuretic peptide measurement in heart failure
    • 5
    • PDF

    References

    SHOWING 1-10 OF 78 REFERENCES
    Use of NT‐proBNP in routine testing and comparison to BNP
    • 151
    Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.
    • 779
    • PDF
    Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    • 59